Lemaitre Vascular (LMAT) Cash & Current Investments (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Cash & Current Investments data on file, last reported at $367.2 million in Q1 2026.

• Quarterly Cash & Current Investments rose 21.38% year-over-year to $367.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $367.2 million (up 21.38% YoY) and the FY2025 annual result came in at $359.1 million, up 19.82% from the prior year.
• Cash & Current Investments improved to $367.2 million in Q1 2026 per LMAT's latest filing, from $359.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $367.2 million in Q1 2026 and bottomed at $70.9 million in Q1 2022.
• The 5-year median for Cash & Current Investments is $108.3 million (2024), against an average of $177.6 million.
• The widest annual swing landed in 2022, when Cash & Current Investments jumped 247.87%; it then increased 14.28% in 2023.
• Tracing LMAT's Cash & Current Investments over 5 years: stood at $82.7 million in 2022, then gained by 27.07% to $105.1 million in 2023, then jumped by 185.25% to $299.7 million in 2024, then advanced by 19.82% to $359.1 million in 2025, then increased by 2.26% to $367.2 million in 2026.
• Per Business Quant, the three latest LMAT Cash & Current Investments figures stand at $367.2 million (Q1 2026), $359.1 million (Q4 2025), and $343.1 million (Q3 2025).

Peer Comparison